What is Acutus Medical, Inc. (AFIB) stock price today?

Acutus Medical, Inc. (AFIB) is currently trading at $0.00.

What is AFIB P/E ratio?

Acutus Medical, Inc.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is AFIB return on equity (ROE)?

Acutus Medical, Inc.'s return on equity (ROE) is 83.33%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Acutus Medical, Inc.'s market cap?

Acutus Medical, Inc. has a market capitalization of $2991.

OTC · Medical - Devices

Acutus Medical, Inc. (AFIB) Stock

$0.00 OTC: AFIB Healthcare

Valuation

Metric	Value
Price	$0.00
Market Cap	$2991
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.00
EPS (TTM)	$-0.32
52-Week High	$0.01
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	83.33%
ROA	-34.48%
ROCE	-0.35%
Gross Margin	0.00%
Operating Margin	-0.28%
Net Margin	-50.00%
Debt/Equity	-3.00
Current Ratio	2.17

Annual Financials (USD)

Metric	2020	2021	2022	2023	2024
Revenue	$8.0M	$17.0M	$3.0M	$7.0M	$20.0M
Operating Profit	$-91.0M	$-116.0M	$-23.0M	$-14.0M	$0
Net Profit	$-102.0M	$-118.0M	$-40.0M	$-82.0M	$-10.0M
EPS	$-8.94	$-4.11	$-1.39	$-2.81	$-0.32
Op Margin	-1079.1%	-671.2%	-757.9%	-200.5%	-0.3%

Balance Sheet (USD)

Metric	2020	2021	2022	2023	2024
Total Assets	$193.0M	$170.0M	$133.0M	$54.0M	$29.0M
Total Liabilities	$66.0M	$64.0M	$58.0M	$55.0M	$40.0M
Cash	$25.0M	$24.0M	$26.0M	$19.0M	$14.0M
Borrowings	$41.0M	$45.0M	$39.0M	$38.0M	$36.0M

Cash Flow (USD)

Metric	2020	2021	2022	2023	2024
Operating Cash Flow	$-85.0M	$-100.0M	$-85.0M	$-63.0M	$-32.0M
Investing Cash Flow	$-75.0M	$9.0M	$97.0M	$58.0M	$22.0M
Financing Cash Flow	$-2.0M	$-3.0M	$-2.0M	$-3.0M	$0
Net Cash Flow	$16.0M	$-1.0M	$7.0M	$-5.0M	$-12.0M
Free Cash Flow	$-96.0M	$-110.0M	$-89.0M	$-63.0M	$-32.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	9.67
FCF Yield	-1062253.43%
Quick Ratio	1.91
Interest Coverage	-0.01
Return 1Y	-92.59%
Return 3Y	-99.99%
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ARDSAridis Pharmaceuticals, Inc.	$0.00	—	0.00	$4457	0.00%
CGHCCapital Group Holdings, Inc.	$0.00	—	-0.01	$9220	0.00%
EVLOEvelo Biosciences, Inc.	$0.00	—	0.00	$1898	0.00%
ICCTiCoreConnect Inc.	$0.00	—	0.00	$5365	0.00%
IGNTIngen Technologies, Inc.	$0.00	—	-0.12	$4480	0.00%

About Acutus Medical, Inc.

Acutus Medical, Inc. is a company dedicated to the treatment of cardiac arrhythmias, focusing on the design, manufacturing, and commercialization of specialized tools for catheter-based ablation procedures. These solutions are utilized to manage a spectrum of heart rhythm disorders across both domestic U.S. and international markets. The firm's extensive product offerings include innovative access sheaths, transseptal crossing devices, diagnostic and mapping catheters, along with both traditional and contact-force ablation catheters. It also provides advanced mapping and imaging consoles, accompanying accessories, and vital supporting algorithms and software. Acutus Medical, Inc. was established in 2011 and is headquartered in Carlsbad, California.

Acutus Medical, Inc. (AFIB) stock trades at $0.00 with a market capitalization of $2991. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.

On profitability, Acutus Medical, Inc. generates a return on equity (ROE) of 83.33% — well above the market average, a sign of a high-quality business, return on capital employed of -0.35%, an operating margin of -0.28%, a net profit margin of -50.00%.

Official website: www.acutusmedical.com